These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31538282)

  • 1. A modeling and simulation-based assessment of the impact of confounding factors on the readout of a sildenafil survival trial in pulmonary arterial hypertension.
    Chanu P; Gao X; Bruno R; Claret L; Harnisch L
    J Pharmacokinet Pharmacodyn; 2019 Oct; 46(5):499-509. PubMed ID: 31538282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
    Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
    Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
    Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
    Beghetti M; Rudzinski A; Zhang M
    BMC Cardiovasc Disord; 2017 Jul; 17(1):177. PubMed ID: 28676038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study.
    Hidayati F; Gharini PPR; Hartopo AB; Anggrahini DW; Dinarti LK
    Health Qual Life Outcomes; 2020 Aug; 18(1):278. PubMed ID: 32795300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
    Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases.
    Torbicki A; Bacchi M; Delcroix M; Farber HW; Ghofrani HA; Hennessy B; Jansa P; Mehta S; Perchenet L; Pulido T; Rosenberg D; Rubin LJ; Sastry BKS; Simonneau G; Sitbon O; Souza R; Wei LJ; Channick R; Benza R
    Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005095. PubMed ID: 31109190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil for Pulmonary Arterial Hypertension.
    Bhogal S; Khraisha O; Al Madani M; Treece J; Baumrucker SJ; Paul TK
    Am J Ther; 2019; 26(4):e520-e526. PubMed ID: 30946047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pulmonary arterial hypertension using extemporaneous formulation of sildenafil in Mexican children.
    Juárez Olguín H; Camacho Reyes L; Roldan Arce A; Calderón Guzmán D
    Pediatr Cardiol; 2015 Jun; 36(5):1019-23. PubMed ID: 25612785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
    Magee AG; Makhecha S; Bentley S
    Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
    Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
    Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
    Rhee SJ; Shin SH; Oh J; Jung YH; Choi CW; Kim HS; Yu KS
    Sci Rep; 2022 May; 12(1):7393. PubMed ID: 35513541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on metal-organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension.
    Mohamed NA; Abou-Saleh H; Kameno Y; Marei I; de Nucci G; Ahmetaj-Shala B; Shala F; Kirkby NS; Jennings L; Al-Ansari DE; Davies RP; Lickiss PD; Mitchell JA
    Sci Rep; 2021 Feb; 11(1):4336. PubMed ID: 33619326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost A; Engel P; Kramer MR; Serdarevic-Pehar M; Layton GR; Sitbon O; Badesch DB;
    J Heart Lung Transplant; 2014 Jul; 33(7):689-97. PubMed ID: 24815795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil in pediatric pulmonary arterial hypertension.
    Dhariwal AK; Bavdekar SB
    J Postgrad Med; 2015; 61(3):181-92. PubMed ID: 26119438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial.
    Russell S; Beghetti M; Oudiz R; Balagtas C; Zhang M; Ivy D
    Open Heart; 2019; 6(2):e001149. PubMed ID: 31908813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
    Dardi F; Manes A; Palazzini M; Bachetti C; Mazzanti G; Rinaldi A; Albini A; Gotti E; Monti E; Bacchi Reggiani ML; Galiè N
    Eur Respir J; 2015 Aug; 46(2):414-21. PubMed ID: 26022952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil for the treatment of pulmonary hypertension in children.
    Beghetti M; Wacker Bou Puigdefabregas J; Merali S
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.